Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H20N4O5 |
Molecular Weight | 456.4501 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=CC=C2)C(O)=O
InChI
InChIKey=KGSXMPPBFPAXLY-UHFFFAOYSA-N
InChI=1S/C25H20N4O5/c1-2-33-24-26-20-9-5-8-19(23(30)31)21(20)29(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-27-25(32)34-28-22/h3-13H,2,14H2,1H3,(H,30,31)(H,27,28,32)
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175561
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
||
|
NCI_THESAURUS |
C66930
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
||
|
LIVERTOX |
NBK548036
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL57242
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
m2173
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | Merck Index | ||
|
135415867
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
TT-131
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
Azilsartan
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
8724
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
N0000178477
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | Decreased Blood Pressure [PE] | ||
|
68850
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
147403-03-0
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
SUB31561
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
DTXSID70163712
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
C521273
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
1091643
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | RxNorm | ||
|
F9NUX55P23
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
F9NUX55P23
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
DB08822
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
N0000180999
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | Angiotensin 2 Type 1 Receptor Antagonists [MoA] | ||
|
100000124198
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
C75107
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
8208
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
AZILSARTAN
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
PRODRUG (METABOLITE ACTIVE)
PRODRUG (METABOLITE ACTIVE)
SALT/SOLVATE (PARENT)